Hochschulschrift
Neurological complications associated with cancer immunotherapies - allogeneic stem cell transplantation, immune checkpoint inhibition, and CAR T cell therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
XI, 268 Seiten
- Language
-
Englisch
- Notes
-
Illustrationen, Diagramme
Enthält Zeitschriftenaufsätze
Albert-Ludwigs-Universität Freiburg, Dissertation, 2022
- Keyword
-
T-Lymphozyt
Immun-Checkpoint
Immuntherapie
- Event
-
Veröffentlichung
- (where)
-
Freiburg im Breisgau
- (when)
-
October 2022
- Creator
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
- 11.06.2025, 1:56 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Time of origin
- October 2022
Other Objects (12)
Allogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Molecular imaging biomarkers for cell-based immunotherapies
Tuning the performance of CAR T cell immunotherapies
Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies
Allogeneic Stem Cell Transplantation with CD34+ Cell Selection
Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Development of NK cell-based cancer immunotherapies through receptor engineering
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
Allogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Molecular imaging biomarkers for cell-based immunotherapies
Tuning the performance of CAR T cell immunotherapies
Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies
Allogeneic Stem Cell Transplantation with CD34+ Cell Selection
Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Development of NK cell-based cancer immunotherapies through receptor engineering
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
Allogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Molecular imaging biomarkers for cell-based immunotherapies
Tuning the performance of CAR T cell immunotherapies
Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies
Allogeneic Stem Cell Transplantation with CD34+ Cell Selection
Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Development of NK cell-based cancer immunotherapies through receptor engineering